T56.7X
Toxic effects of beryllium and its compounds
Clinical Classification Guidelines
Medical Intelligence & Overview
The ICD-10 code T56.7X refers to the toxic effects caused by exposure to beryllium and its compounds. Beryllium is a lightweight metal used in various industries, including aerospace, electronics, and nuclear facilities. While beneficial in many applications, exposure to beryllium can lead to health issues, especially if inhaled or comes into contact with the skin. Recognizing the symptoms and understanding the causes of beryllium toxicity are essential for managing health risks associated with this element.
Causes & Symptoms
Clinical Causes: Occupational exposure to beryllium dust, fumes, or mist during manufacturing or processing industries. Handling or working with beryllium-containing materials without proper protective equipment. Inadequate ventilation in workplaces where beryllium is processed or used. Accidental ingestion or skin contact with beryllium compounds in laboratory or industrial settings.
Key Symptoms: Persistent cough and shortness of breath Chest pain or tightness Fatigue and general weakness Weight loss over time Skin rashes or irritation in areas of contact Flu-like symptoms such as fever and chills Mouth or throat irritation if ingested
Diagnostic & Treatment
Diagnosis Path: Diagnosing beryllium toxicity involves a combination of patient history, physical examination, and laboratory tests. Medical professionals may inquire about occupational history to assess potential exposure. Diagnostic tests can include:
Treatment Protocols: There is no specific antidote for beryllium toxicity. Treatment strategies focus on managing symptoms and preventing further exposure. Medical management may include:
Clinical Advice & FAQs
Billing Guidance
Is T56.7X a billable ICD-10 code?
Yes, T56.7X is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T56.7X?
Clinical documentation must specify the nature of Toxic effects of beryllium and its compounds and any associated comorbidities for accurate reporting.
Cite this Clinical Reference